ANRO: the cash flow

MyFinsight

For the year ending 2025-12-31, ANRO had $8,255K increase in cash & cash equivalents over the period. -$51,793K in free cash flow.

Cash Flow	2025-12-31
Net loss	-63,238
Stock-based compensation expense	8,108
Depreciation	661
Non-cash research and development license expense	0
Non-cashlease expense	774
Non-cash interest expense related to term loan	729
Loss on disposal of assets	-156
Other	327
Loss on debt extinguishment	-681
Prepaid expenses and other assets	-101
Accounts payable	221
Accrued liabilities and other liabilities	-289
Net cash used in operating activities	-51,769
Capital expenditures	24
Net cash used in investing activities	-24
Proceeds from sale of common stock and pre-funded warrants in private placement	50,000
Payments from sale of common stock and pre-funded warrants in private placement	167
Proceeds from issuance of common stock from initial public offering	0
Payments of issuance costs-IPO	0
Payments on issuance cost from registration statement	556
Proceeds from issuance of term loan, net	19,688
Repayment of former term loan	10,213
Payment of loan financing cost	127
Payments of issuance costs-Series BAnd Series CPreferred Stock	0
Proceeds from convertible grant agreement	750
Proceeds from exercise of stock options	703
Net cash provided by financing activities	60,078
Effect of exchange rate changes on cash, cash equivalents and restricted cash	-30
Net increase in cash, cash equivalents and restricted cash	8,255
Cash, cash equivalents and restricted cash at the beginning of the period	168,729
Cash, cash equivalents and restricted cash at the end of the period	176,984

Unit: Thousand (K) dollars (except for numbers of shares and EPS).